Keywords: داروهای قلب و عروق; Cardiovascular drugs; Deep eutectic solvents; Green liquid chromatography; Hydrochlorothiazide; Losartan potassium; Triamterene;
مقالات ISI داروهای قلب و عروق (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Natural products; Drug transporters; Natural product-drug interaction; Pharmacokinetics;
Keywords: داروهای قلب و عروق; Pharmacokinetics; Pharmacodynamics; Cardiovascular drugs; Chronic heart failure;
Keywords: داروهای قلب و عروق; Bovine serum albumin; Cardiovascular drugs; Binding; Electrochemistry; Nano-science;
Keywords: داروهای قلب و عروق; Pediatric heart failure; Patient safety; Acute heart failure; Chronic heart failure; Clinical trials; Cardiovascular drugs
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Oral adverse effects; Dry mouth; Angioedema; Dysgeusia; Gingival enlargement;
Keywords: داروهای قلب و عروق; ASCVD; atherosclerotic cardiovascular disease; LDL-C; low density lipoprotein cholesterol; Cardiovascular diseases; Cardiovascular drugs; Clinical practice guidelines; Enfermedades cardiovasculares; Fármacos cardiovasculares; GuÃa de práctica clÃnica;
Keywords: داروهای قلب و عروق; ASCVD, enfermedad cardiovascular aterosclerótica; cLDL, colesterol unido a lipoproteínas de baja densidadEnfermedades cardiovasculares; Fármacos cardiovasculares; Guía de práctica clínicaCardiovascular diseases; Cardiovascular drugs; Clinical practice gui
Keywords: داروهای قلب و عروق; Label; Cardiovascular drugs; Pregnancy; Safety information;
Keywords: داروهای قلب و عروق; Hypertension; Blood pressure; Cardiovascular drugs; Medical guidelines; Antihypertensive
Update of green tea interactions with cardiovascular drugs and putative mechanisms
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Green tea; Herb-drug interactions;
Structural characterization of electrochemically and in vivo generated potential metabolites of selected cardiovascular drugs by EC-UHPLC/ESI-MS using an experimental design approach
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Electrochemistry; Liquid chromatography; Mass spectrometry; Metabolism;
Electrochemical simulation of three novel cardiovascular drugs phase I metabolism and development of a new method for determination of them by liquid chromatography coupled with tandem mass spectrometry
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Liquid chromatography; Electrochemistry; Extraction; Mass spectrometry;
Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx)
Keywords: داروهای قلب و عروق; Pharmacogenomics; Pharmacogenetics; Cardiovascular drugs; Clinical implementation;
Chronic β1-adrenoceptor blockade impairs ischaemic tolerance and preconditioning in murine myocardium
Keywords: داروهای قلب و عروق; β-Adrenoceptors; Cardiac ischaemia; Cardiovascular drugs; Ischaemia-reperfusion injury; Morphine
Farmacogenómica: Aplicaciones cardiovasculares
Keywords: داروهای قلب و عروق; Farmacogenética; farmacogenómica; medicamentos cardiovasculares; farmacocinética; farmacodinamia.Pharmacogenetics; pharmacogenomics; cardiovascular drugs; pharmacokinetics; pharmacodynamics.
Chromatographic behavior of co-eluted plasma compounds and effect on screening of drugs by APCI-LC–MS(/MS): Applications to selected cardiovascular drugs
Keywords: داروهای قلب و عروق; Plasma; APCI-LC–MS; Cardiovascular drugs; Matrix effects; Recovery
Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure
Keywords: داروهای قلب و عروق; Age; Cardiovascular drugs; Systolic heart failure; Heart failure with preserved ejection fraction; Left ventricular ejection fractionÂge; Médicaments cardiovasculaires; Insuffisance cardiaque systolique; Insuffisance cardiaque avec fraction d’éjection pré
Faut-il adapter les médicaments antidiabétiques et cardiovasculaires chez la personne âgée diabétique ?
Keywords: داروهای قلب و عروق; Diabète; sujets âgés; antidiabétiques; médicaments cardiovasculaires; adaptation thérapeutique; Diabetes; elderly; antidiabetic drugs; cardiovascular drugs; therapeutic adaptation;
Ligand action on sodium, potassium, and calcium channels: role of permeant ions
Keywords: داروهای قلب و عروق; cardiovascular drugs; immunosuppressants; local anesthetics; batrachotoxin; voltage dependence; use dependence
Bisoprolol, ramipril and simvastatin determination in dried blood spot samples using LC–HRMS for assessing medication adherence
Keywords: داروهای قلب و عروق; PK, pharmacokinetics; DBS, dried blood spot; LC–HRMS, liquid chromatography–high resolution mass spectrometryDried blood spot (DBS); LC–HRMS; Cardiovascular drugs; Adherence
An LC–MS assay for the screening of cardiovascular medications in human samples
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Drug monitoring; Selectivity; Mass spectrometry; Liquid chromatography; Clinical samples
Severe lactose intolerance in a patient with coronary artery disease and ischemic cardiomyopathy
Keywords: داروهای قلب و عروق; Lactose intolerance; Cardiovascular drugs; Coronary disease; Myocardial infarction; Ischemic cardiomyopathyIntolerância à lactose; Fármacos cardiovasculares; Doença coronária; Enfarte do miocárdio; Cardiomiopatia isquémica
Severe lactose intolerance in a patient with coronary artery disease and ischemic cardiomyopathy
Keywords: داروهای قلب و عروق; Lactose intolerance; Cardiovascular drugs; Coronary disease; Myocardial infarction; Ischemic cardiomyopathyIntolerância à lactose; Fármacos cardiovasculares; Doença coronária; Enfarte do miocárdio; Cardiomiopatia isquémica
Prevalencia de sÃndrome metabólico en pacientes con enfermedad coronaria estable: objetivos terapéuticos y utilización de fármacos cardiovasculares
Keywords: داروهای قلب و عروق; SÃndrome metabólico; Enfermedad coronaria; Fármacos cardiovasculares; Metabolic syndrome; Coronary disease; Cardiovascular drugs;
Development of an LC–MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy
Keywords: داروهای قلب و عروق; LC–MS/MS; Metabolic syndrome; Matrix effect; Cardiovascular drugs
Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Non-antibiotic; Helper compound; Amlodipine; Microbial infections
A hybrid hierarchical decision support system for cardiac surgical intensive care patients. Part I: Physiological modelling and decision support system design
Keywords: داروهای قلب و عروق; Cardiac intensive care unit; Cardiovascular system model; Hemodynamics; Cardiovascular drugs; Clinical decision support system; Fuzzy control; Genetic algorithms
Enzymes and pharmacogenetics of cardiovascular drugs
Keywords: داروهای قلب و عروق; Pharmacogenetics; Pharmacogenomics; Pharmacokinetics; Pharmacodynamics; Cardiovascular drugs; Cytochrome; P450
Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhytmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry: Method developm
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Beta-blockers; Calcium-channel antagonists; Angiotensin-II antagonists; Antiarrythmic drug; Whole blood; Experimental design; SPE; HPLC-MS
Aspirin sensitivity of platelet aggregation in diabetes mellitus
Keywords: داروهای قلب و عروق; Platelet aggregation; Aspirin sensitivity; Diabetes mellitus; Cardiovascular drugs;
A population-based study on well-being in the very old: the role of cardiovascular diseases and drugs
Keywords: داروهای قلب و عروق; Well-being; Old people; Population-based; Cardiovascular diseases; Cardiovascular drugs;
Paediatric formulations-Getting to the heart of the problem
Keywords: داروهای قلب و عروق; Cardiovascular drugs; Paediatric medicines; Licensed liquid; Special products; Extemporaneous preparations;